Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
James Rohack, MD, President of the American Medical Association, discusses the ongoing debate over health system reform in an interview with Michael Banks, MD, co-founder of The Doctor’s…
NEW YORK (Reuters Health) – Given that arterial lines are used less frequently in pediatric ICUs these days, the criteria for diagnosis of acute lung injury are less…
NEW YORK (Reuters Health) – The combination of pentoxifylline and vitamin E prevented radiation-induced lymphedema among breast cancer patients in a phase II trial in Sweden. The finding…
NEW YORK (Reuters Health) – Starting estrogen-progestogen therapy close to menopause may increase the risk of breast cancer, even with short-duration treatment, according to a report in the…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), the antiarrhythmic dronedarone is less effective than amiodarone at maintaining sinus rhythm, but it has fewer adverse…
NEW YORK (Reuters Health) – New research indicates that the outcomes of localized prostate cancer following conservative management have improved in the last few decades. According to the…
NEW YORK (Reuters Health) – When patients who need coronary artery bypass grafts or an aortic valve have significant carotid stenosis, some surgeons combine the cardiac surgery with…
NEW YORK (Reuters Health) – Biomarkers of endothelial dysfunction are elevated in premenopausal women with migraine, which may help to explain the link between migraine and strokes, according…
NEW YORK (Reuters Health) – Although dimenhydrinate can reduce vomiting in children with acute gastroenteritis, it does not improve oral rehydration or clinical outcomes, according to a report…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
